News

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
Dr. Natalie Kreitzer discusses new TBI care advancements, including a blood biomarker test and quantitative pupillometry in ...
The pituitary gland, located at the base of the brain, secretes hormones that control vital bodily functions and also regulates the activity of other ...
Multivariate logistic regression analysis indicated that, in comparison to the control group, postoperative constipation ...
What began as a simple headache turned into a life-threatening infection for a 25-year-old woman until doctors discovered the ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new ...
Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...
Brain tumours may lead to headaches by raising pressure inside the skull compressing sensitive structures or disrupting the ...
Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...
Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...